Found 5 matching trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
Arizona Clinical Research Center
Learn More & Join Trial
Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse PHASE2 RATIONALE: Drugs used in chemotherapy, such as pixantrone, cytarabine, meth...
Show More Location
Arizona Oncology Associates - Craycroft Road Offices
Learn More & Join Trial
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma PHASE3 RATIONALE: Drugs used in chemotherapy, such as fludarabine and pixantrone, ...
Show More Location
Cell Therapeutics, Incorporated
Learn More & Join Trial
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant PHASE3 The purpose of this study is to evaluate the efficacy of Pixantrone + Ritux...
Show More Location
Arizona Clinical Research Center
Learn More & Join Trial
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as pixantrone dimaleate, work i...
Show More Location
Poudre Valley Hospital
Learn More & Join Trial